Please login to the form below

Not currently logged in
Email:
Password:

The Competition and Markets Authority

This page shows the latest The Competition and Markets Authority news and features for those working in and with pharma, biotech and healthcare.

Roche to close $4.3bn Spark deal after FTC clearance

Roche to close $4.3bn Spark deal after FTC clearance

The US antitrust approval swiftly follows the clearance from the UK’s Competition and Markets Authority (CMA), which announced early yesterday that its investigation into the merger was complete. ... However, the antitrust authority finally concluded

Latest news

  • UK’s CMA clears Roche’s $4.3bn takeover of Spark UK’s CMA clears Roche’s $4.3bn takeover of Spark

    the UK's Competition and Markets Authority (CMA) finally approved the deal. . ... The CMA therefore found that the deal between Roche and Spark would not negatively affect competition because UK health services and patients will still have an adequate

  • Pfizer, Flynn face reinstatement of £90m CMA fine Pfizer, Flynn face reinstatement of £90m CMA fine

    Facing penalty for dramatic price hikes of an epilepsy drug. The UK’s competition regulator is pushing to reinstate a £90m fine for Pfizer and Flynn Pharma – quashed last year – over ... The case dates back to 2015, when the Competition and

  • Roche moving closer to approval of Spark takeover; report Roche moving closer to approval of Spark takeover; report

    Competition and Markets Authority (CMA) have taken their time to probe antitrust issued raised by the deal. ... The Capitol Forum report suggests that review staff are happy to accept the deal, but that senior officials at the FTC's Bureau of

  • UK government raises concerns about Illumina’s $1.2bn takeover of PacBio UK government raises concerns about Illumina’s $1.2bn takeover of PacBio

    The Competition and Markets Authority (CMA) has raised concerns that the merger of Illumina and Pacific Biosciences of California (PacBio) will lead to a loss of innovation in the DNA sequencing ... PacBio will cause a loss of competition between the two

  • Aspen to pay millions to NHS following drug pricing investigation Aspen to pay millions to NHS following drug pricing investigation

    South African pharma company Aspen is set to pay the NHS £8m ($9.9m) in the next few weeks, after an investigation by the UK’s Competition and Markets Authority (CMA) ... The CMA has today provisionally found that Aspen, Amilco and Tiofarma broke

More from news
Approximately 0 fully matching, plus 14 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 2 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...

Infographics